NCT05961553 is a NA clinical trial of Physical Activity Counseling session in COPD, sponsored by Polytechnic Institute of Porto.

Who is sponsoring NCT05961553?

NCT05961553 is sponsored by Polytechnic Institute of Porto.

What drugs are being tested in NCT05961553?

Interventions in NCT05961553: Physical Activity Counseling session, Pulmonary Reabilitation.

Is NCT05961553 still recruiting?

NCT05961553 is currently completed. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT05961553

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Individual Counseling Session on Physical Activity Level of Individuals With COPD

Completed NA Last updated 12 February 2025

What this trial tests

NA trial testing Physical Activity Counseling session in COPD in 22 participants. Completed in 31 December 2023.

Timeline

1 December 2022

Primary endpoint
30 September 2023

31 December 2023

Quick facts

Lead sponsor	Polytechnic Institute of Porto
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	22
Start date	1 December 2022
Primary completion	30 September 2023
Estimated completion	31 December 2023
Sites	1 location across Portugal

Drugs / interventions tested

Physical Activity Counseling session
Pulmonary Reabilitation

Conditions studied

COPD — all drugs for COPD →

Sponsor

Polytechnic Institute of Porto

Who can join

40 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized clinical trial is to study the effect of an individual counseling session on the level of physical activity and motivation to practice physical exercise in individuals with COPD. The main question\[s\] it aims to answer are: • Does a counseling session improve the level of physical activity and motivation to practice physical exercise in individuals with COPD? Participants will perform a respiratory rehabilitation program (Control Group, CG) and a respiratory rehabilitation program and the counseling session (Experimental Group, EG). Researchers will compare EG to CG to see if there is any difference in physical activity level and motivation to exercise between groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Polytechnic Institute of Porto trials

Trials by the same sponsor.

NCT07474974 — ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive D · NA · not yet recruiting
NCT06997861 — Medication Review Improves Pain Management and Quality of Life in Chronic Pain · NA · completed
NCT05814978 — Effects of Scapular Therapeutic Exercise on Essential Biomechanical and Neurophysiological Parameters in Shoulder Pain C · NA · completed
NCT05611723 — Study and Analysis of Biomechanical Parameters of Human Movement Based on Disability Indicators in Older Adults · completed
NCT05656690 — Prospective Study and Analysis of Biomechanical Parameters of Human Movement Based on Disability Indicators in Older Adu · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05961553 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Polytechnic Institute of Porto
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05961553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing